BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is an orthobiologics company. It specializes in developing and commercializing injectable bio-ceramic bone graft substitutes designed to promote bone healing by remodeling the patient’s bone. The company’s products, based on its patented Cerament platform, are effective for treating bone defects caused by disease, trauma, infection, or surgery. Cerament products are engineered to promote osteoconduction, resorb at a rate matching bone formation, and integrate seamlessly with the bone. BoneSupport’s product line includes Cerament Bone Void Filler, Cerament G with gentamicin, and Cerament V with vancomycin, providing patient-friendly solutions for single-stage surgeries. It also provides the Cerament Bead Tray that offers targeted delivery to bone defects. BoneSupport is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Report Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- BoneSupport AB Company Overview
- BoneSupport AB Company Snapshot
- BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
- BoneSupport AB - Pipeline Analysis Overview
- Business Description
- BoneSupport AB - Key Facts
- BoneSupport AB - Major Products and Services
- BoneSupport AB Pipeline Products by Development Stage
- BoneSupport AB Ongoing Clinical Trials by Trial Status
- BoneSupport AB Pipeline Products Overview
- Cerament + Bisphosphonate
- Cerament + Bisphosphonate Product Overview
- Cerament + Bisphosphonates And BMP
- Cerament + Bisphosphonates And BMP Product Overview
- Cerament + BMP
- Cerament + BMP Product Overview
- Cerament + BMP 2
- Cerament + BMP 2 Product Overview
- Cerament Plus BMP And Stem Cells
- Cerament Plus BMP And Stem Cells Product Overview
- CERAMENT V
- CERAMENT V Product Overview
- CERAMENT V Clinical Trial
- Gelatin/Cerament
- Gelatin/Cerament Product Overview
- BoneSupport AB - Key Competitors
- BoneSupport AB - Key Employees
- BoneSupport AB - Key Employee Biographies
- BoneSupport AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- BoneSupport AB, Recent Developments
- Apr 14, 2026: CMS Proposes Improved Payment for Cerament G in the U.S.
- Mar 06, 2026: US Clinical Data Highlight Cerament G in Infection Prevention for Trauma Patients
- Feb 27, 2026: Published US Pilot Study Highlights Clinical Experience With Cerament G in Trauma
- Dec 02, 2025: CERAMENT V Application in the U.S. Transferred to the De Novo Process
- Sep 16, 2025: No infection recurrence when using CERAMENT G in infected hip implant management
- Sep 15, 2025: Bonesupport Holding AB (publ): Strong CERAMENT Results Presented
- Aug 12, 2025: CMS Approves NTAP for Cerament G in Open Fractures, Providing Additional Hospital Reimbursement Starting October 1, 2025
- Apr 01, 2025: Bonesupport Files FDA Submission for Cerament V
- Jan 07, 2025: Cerament G and Cerament V Contributes to Improved Survival Rates
- Oct 03, 2024: Additional Data From SOLARIO Study Reveals Further Positive Insights
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
- BoneSupport AB Pipeline Products by Equipment Type
- BoneSupport AB Pipeline Products by Indication
- BoneSupport AB Ongoing Clinical Trials by Trial Status
- BoneSupport AB, Key Facts
- BoneSupport AB, Major Products and Services
- BoneSupport AB Number of Pipeline Products by Development Stage
- BoneSupport AB Pipeline Products Summary by Development Stage
- BoneSupport AB Ongoing Clinical Trials by Trial Status
- BoneSupport AB Ongoing Clinical Trials Summary
- Cerament + Bisphosphonate - Product Status
- Cerament + Bisphosphonate - Product Description
- Cerament + Bisphosphonates And BMP - Product Status
- Cerament + Bisphosphonates And BMP - Product Description
- Cerament + BMP - Product Status
- Cerament + BMP - Product Description
- Cerament + BMP 2 - Product Status
- Cerament + BMP 2 - Product Description
- Cerament Plus BMP And Stem Cells - Product Status
- Cerament Plus BMP And Stem Cells - Product Description
- CERAMENT V - Product Status
- CERAMENT V - Product Description
- CERAMENT V - Post-market Study of Cerament V/G in Foot Osteomyelitis
- CERAMENT V - Use of Bone Cement Versus Bone Substitute Material in Two-Stage Replacement of Septic Hip Endoprostheses
- Gelatin/Cerament - Product Status
- Gelatin/Cerament - Product Description
- BoneSupport AB, Key Employees
- BoneSupport AB, Key Employee Biographies
- BoneSupport AB, Subsidiaries
- Glossary
- BoneSupport AB Pipeline Products by Equipment Type
- BoneSupport AB Pipeline Products by Development Stage
- BoneSupport AB Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Promimic AB
- Wright Medical Deutschland GmbH
- Graftys SA
- DOT GmbH
- Kuros Biosciences AG
